| ¿µ¹® | positron emission tomography | ÇÑ±Û | ¾çÀüÀÚ¹æÃâ ´ÜÃþÃÔ¿µ |
|---|---|---|---|
| ¼³¸í | ÇÙÀÇÇÐÀû Áø´Ü¹æ¹ýÁß Çϳª. °¡Àå ¹ß´ÞµÈ ÇüÅÂÀÇ ÇÙÀÇÇÐÀû Áø´Ü¹æ¹ýÀÌ´Ù. ¾çÀüÀÚ¸¦ ¹æÃâÇÔÀ¸·Î½á »ý±â´Â ÇÙÀÇÇÐÀû ¹æ»ç´ÉÀ» ÀÌ¿ëÇÏ¿© ÀÎüÀÇ ´Ü¸éÀ» ÃÔ¿µÇÒ ¼ö ÀÖ´Ù. À̰ÍÀº ¸¶Ä¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ°ú À¯»çÇϳª, Á¶¿µÁ¦¿Í X-¼±À» »ç¿ëÇÏÁö ¾Ê´Â´Ù´Â Á¡¿¡¼ ´Ù¸£´Ù. ÀÌ¿ëÇÏ´Â ÇÙÀÇÇÐÀû ¹°ÁúÀ» ÀÎü³»¿¡¼ ´ë»ç°¡´ÉÇÑ ¹°Áú(¿¹¸¦ µé¾î Æ÷µµ´ç, ȤÀº Áö¹æ)¿¡ ºÙ¿©¼ »ç¿ëÇÔÀ¸·Î½á, ½ÇÁ¦ÀûÀ¸·Î »ì¾ÆÀÖ´Â »ýü³»¿¡¼ ¾î¶² ÇüÅ·Π´ë»ç°¡ ÀÌ·ç¾îÁö´Â Áö ¾Ë¾Æ³¾ ¼öµµ ÀÖ´Ù. ¿¹¸¦ µé¸é, ´«À» ¶ß°í ¾î¶² ¹°Ã¼¸¦ ÁÖ½ÃÇÒ ¶§, ³úÀÇ ¾î¶² ºÎÀ§°¡ °¡Àå Ȱ¹ßÇÑ ´ë»çÀÛ¿ëÀ» ÇÏ´ÂÁö ¾Ë ¼ö ÀÖ´Ù. |
||
| ECL | emitter-coupled logic; enterochromaffin-like [type]; euglobin clot lysis |
|---|---|
| RE | radium emanation; readmission; rectal examination; reference emitter; reflux esophagitis; regional e... |
| PET | Positron Emission Tomography |
| e+ | positron |
| PCT | peripheral carcinoid tumor; plasma clotting time; plasmacrit test; plasmacytoma; polychlorinated tri... |
| FDG PET | 2-(18)fluoro-2-deoxy-D-glucose positron emission tomography |
|---|---|
| FDG PET | F-18-fluorodeoxyglucose positron emission tomography |
| FDG-PET | Fluorodeoxy-glucose-positron emission tomography |
| PET | Positron Emission Computed Tomography |
| PET | Positron Emission Tomographic |
| emitter | <physics, radiobiology> A radionuclide whose decay is accompanied by the emission of beta particles, most commonly negatively charged electrons. Many isotopes used in biology, such as 3H, 14C, 35S and 32P are pure beta emitters. (18 Nov 1997) |
|---|---|
| positron | A subatomic particle of mass and charge equal to the electron but of opposite (i.e., positive) charge. Synonym: positive electron. (05 Mar 2000) |
| positron emission tomography | <radiology> A highly specialised research imaging technique using short lived radioactive substances - usually those made with a cyclotron. This technique is very sensitive in picking up active tumour tissue but does not measure the size of it. Tomographic images are formed by computer analysis of photons detected from annihilation of positrons emitted by radionuclides incorporated into biochemical substances; the images, often quantitated with a colour scale, show the uptake and distribution of the substances in the tissue, permitting analysis and localization of metabolic and physiological function. Because the half-lives of the radionuclides are so short (20 minutes to 2 hours), and the equipment expensive, PET is rarely used in a clinical setting. But since its development in the mid-1970s, it has proved the most important tool yet devised for experimental investigation of the living brain, whether healthy, traumatised, or diseased. With CT and MRI, it represents a new generation of computer imaging techniques that have revolutionised medicine and physiology. Acronym: PET (20 Jun 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|